Article

PPG launches CR-39 Licensed Lens Caster Program

Pittsburgh-PPG Industries Inc. has initiated the CR-39 Licensed Lens Caster Program. The program recognizes lens casters who are dedicated to preserving the reputation of CR-39 monomer.

Pittsburgh-PPG Industries Inc. has initiated the CR-39 Licensed Lens Caster Program. The program recognizes lens casters who are dedicated to preserving the reputation of CR-39 monomer.

Sixty years ago, PPG Industries was awarded the patent for CR-39 monomer, which became the first resin widely used for manufacturing plastic ophthalmic lenses. Today, CR-39 represents the largest category of lenses sold worldwide.

"We feel we should defend the value behind the CR-39 trademark to ensure that the industry is receiving the authentic CR-39 monomer they have depended on for so many years," said Christine Camsuzou, PPG general manager of optical materials.

The CR-39 Licensed Lens Caster Program and its members will be highlighted in advertising and at industry trade shows throughout the year.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.